Skip to main content
Recent Patents on Anti-Infective Drug Discovery publishes review articles on recent patents in the field of anti-infective drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-infective drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-infective drug design and discovery.

Recent Patents on Anti-Infective Drug Discovery is now published as Recent Advances in Anti-Infective Drug Discovery Formerly Recent Patents on Anti-Infective Drug Discovery.

Publisher: Bentham Science Publishers

More about this publication?
Volume 1, Number 3, 2006

Articles

Macrophage Inflammatory Protein 1 and CCR5 as Attractive Therapeutic Targets for HIV Infection
pp. 275-280(6)
Authors: Kasama, Tsuyoshi; Yajima, Nobuyuki; Matsukura, Satoshi; Adachi, Mitsuru

Favourites:
ADD

Listeria-Based Anti-Infective Vaccine Strategies
pp. 281-290(10)
Author: Liu, Dongyou

Favourites:
ADD

Advances in the Development of Inactivated Virus Vaccines
pp. 291-296(6)
Authors: Stauffer, Fausto; El-Bacha, Tatiana; Da Poian, Andrea T.

Favourites:
ADD

SARS Coronavirus Anti-Infectives
pp. 297-308(12)
Author: Tong, Tommy R.

Favourites:
ADD

Poxvirus Cancer Therapy
pp. 309-321(13)
Authors: Gilbert, Philippe-Alexandre; McFadden, Grant

Favourites:
ADD

Recent Patents on Nucleoside and Nucleotide Inhibitors for HCV
pp. 323-331(9)
Authors: Shim, Jae H.; Hong, Zhi; Wu, Jim Z.

Favourites:
ADD

Dendrimer Based Anti-Infective and Anti-Inflammatory Drugs
pp. 333-351(19)
Authors: Heegaard, Peter M. H.; Boas, Ulrik

Favourites:
ADD

Recent Patents and New Strategies in the Treatment of Psoriasis
pp. 353-364(12)
Authors: Saraceno, Rosita; Di Stefani, Alessandro; Giunta, Alessandro; Chimenti, Sergio

Favourites:
ADD

Patent Annotations
pp. 365-368(4)

Favourites:
ADD

Patent Selections
pp. 369-370(2)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content